Curis (CRIS) - P/S ratio

P/S ratio as of November 2026 (TTM): 1.40

According to Curis's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.29. At the end of 2023 the company had a P/S ratio of 7.50.

P/S ratio history for Curis from 2001 to 2023

PS ratio at the end of each year

Year	P/S ratio	Change
2023	7.50	43.71%
2022	5.22	-87.26%
2021	40.9	-38.66%
2020	66.8	1081.79%
2019	5.65	157.53%
2018	2.19	-81.09%
2017	11.6	-79.84%
2016	57.5	20.72%
2015	47.6	263.4%
2014	13.1	-18.77%
2013	16.1	-0.2%
2012	16.2	-33.39%
2011	24.3	155.42%
2010	9.50	-62.68%
2009	25.5	347.65%
2008	5.69	50.44%
2007	3.78	-9.14%
2006	4.16	-73.01%
2005	15.4	-69.21%
2004	50.1	203.15%
2003	16.5	829.16%
2002	1.78	-98.93%
2001	167

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Pfizer PFE	2.63	87.39%	🇺🇸 USA
Bristol-Myers Squibb BMY	2.54	80.88%	🇺🇸 USA
Spectrum Pharmaceuticals SPPI	8.22	485.43%	🇺🇸 USA
Exelixis EXEL	6.80	384.42%	🇺🇸 USA
Celldex Therapeutics CLDX	> 1000	1,057,890.32%	🇺🇸 USA
Cel-Sci CVM	N/A	N/A	🇺🇸 USA
Emergent BioSolutions EBS	0.4197	-70.09%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Curis (CRIS)

P/S ratio as of November 2026 (TTM): 1.40